Tiffany Hood

Tiffany Hood is currently a PhD student in Qasim Rafiq’s Cell and Gene Therapy Bioprocessing research group at University College London (UCL). Her research is focused on how to develop a more automated and reproducible manufacturing process for CAR-T therapies using technologies, such as stirred tank bioreactors. In particular, she is focused on how the manufacturing process can be adapted to account for the variable starting material of autologous cell therapies to enable a more reproducible end product. Prior to UCL, Tiffany was a R&D engineer in the Cell Therapy Bioprocessing group at MilliporeSigma. During her time at MilliporeSigma, she was the technical lead for cell therapy bioreactor process development efforts. She also worked on multiple product development projects for downstream cell therapy products. Additionally, she worked with external collaborators to optimize bioreactor processes for cell therapies in the clinic. Tiffany earned her undergraduate degree in Biological Engineering from Massachusetts Institute of Technology (MIT).